SALMAN SIDDIQUI: Open Payments
NPI 1437110053 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 13 payments from 7 companies in 2025. Trend: 2023 $585 · 2024 $401 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Alkermes, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, REXULTI, INGREZZA, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
